Stock Analiz

Claritev Corp CTEV

Business Services · IPO 2020 · data as of November 13, 2026

$26.82Market cap $458M
Open the interactive analysis →

Claritev Corp (CTEV) is a consumer discretionary company listed in the US with a market value of about $458M. In the twelve months to September 30, 2026 it had revenue of $1.0B and net income of -$275M, a net margin of -27.1%.

Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is value (1/5); the weakest is financial health (0/5).

Key numbers: 5-year revenue growth of 1% a year, a 5-year average ROIC of -5%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 83% above the current price.

About Claritev

Claritev is listed in the US and classified in business services, IPO year 2020. Revenue went from $1.0B in 2018 to $965M in 2025, a decline of about 1.1% a year. It was profitable in 3 of the last 8 years in our data. Its share count rose by 3% over three years (dilution for shareholders).

Score: 0.8 / 5

Value1/5
Future growth1/5
Track record1/5
Financial health0/5
Shareholder returns1/5

Checks passed

  • Price below intrinsic value (DCF, moderate assumptions)
  • Profit margin improving
  • ROE above 15%
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%

Valuation

P/E (TTM)—
Forward P/E3.5
P/FCF—
P/S0.5
P/B—
EV/EBITDA10.5
PEG—
Dividend yield0.00%
FCF yield-6.1%
Shareholder yield0.0%
Intrinsic value vs. price+83%

Growth and quality

Revenue growth (1 yr)3.7%
Revenue growth (5 yrs, per year)0.6%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-51.9%
ROIC (5-yr avg.)-5.1%
Profitable years (of last 10)3
Years paying a dividend—

Financials, last 8 years

Fiscal yearTTM20252024202320222021202020192018
Revenue$1.0B$965M$931M$962M$1.1B$1.1B$938M$983M$1.0B
Net income-$275M-$284M-$1.6B-$92M-$573M$102M-$521M$10M$36M
Free cash flow-$28M-$12M-$11M$63M$283M$320M$307M$218M$229M
EPS (diluted)$-16.42$-17.30$-101.92$-5.69$-36.00$6.40$-44.40$0.80$3.60
Net margin-27.1%-29.4%-176.8%-9.5%-53.1%9.1%-55.5%1.0%3.5%
ROIC—0.5%-27.7%2.2%-4.3%4.0%-1.4%4.7%19.8%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 5 analysts is $48.60, 81% above the current price; targets range from $30.00 to $82.00; the consensus rating is “Buy”; expected EPS is $6.13 for the fiscal year ending December 31, 2026.

Frequently asked questions

Is Claritev stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 83% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Claritev pay a dividend?

Not currently.

Is Claritev a good stock to buy?

We do not give buy or sell advice. Claritev scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.